构建衰老高加索人群数据库以支持生理药代动力学建模
本研究通过结构化文献检索分析年龄相关的系统参数变化,开发并验证了一个包含20至99岁高加索人群解剖、生理和生物学参数变异的群体数据库,共纳入318项研究。该数据库在Matlab®中实现,1000个虚拟个体的估计参数与独立观测数据一致,可用于研究老年人药物动力学和药物相互作用程度。
要点
- 数据库覆盖20至99岁高加索人群,包含年龄依赖的系统参数连续函数和变异。
- 组织组成等数据稀疏区域采用合理假设填补,模型稳健性经独立数据验证。
- 该数据库可为老年人药物动力学和药物相互作用研究提供系统参数来源。
核心结论
- 所开发的衰老受试者数据库为生理药代动力学建模提供关键系统参数的单一特定来源,可用于研究老年人药物动力学和药物相互作用程度。
研究设计与样本
- 通过结构化文献检索分析年龄依赖的系统参数变化,共纳入318项报告人体测量参数和特定器官丰富数据的研究,推导描述性数学方程并在Matlab®中实现包含群体变异的模型。
主要发现
- 大多数系统参数可导出描述20至99岁高加索人群的连续函数并包含变异。
- 识别出组织组成等数据稀疏区域,并用合理的合格假设填补知识空白。
- 1000个虚拟个体的估计系统参数与独立观测数据一致,显示所开发群体的稳健性。
临床怎么用
- 临床药学智能体医生可利用该数据库支持老年人生理药代动力学建模,评估药物动力学和药物相互作用程度。
局限性
- 部分系统参数数据稀疏(如组织组成),知识空白通过合理假设填补而非直接观测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aging is characterized by anatomical, physiological, and biological changes that can impact drug kinetics. The elderly are often excluded from clinical trials and knowledge about drug kinetics and drug-drug interaction magnitudes is sparse. Physiologically based pharmacokinetic modeling can overcome this clinical limitation but detailed descriptions of the population characteristics are essential to adequately inform models. OBJECTIVE: The objective of this study was to develop and verify a population database for aging Caucasians considering anatomical, physiological, and biological system parameters required to inform a physiologically based pharmacokinetic model that included population variability. METHODS: A structured literature search was performed to analyze age-dependent changes of system parameters. All collated data were carefully analyzed, and descriptive mathematical equations were derived. RESULTS: A total of 362 studies were found of which 318 studies were included in the analysis as they reported rich data for anthropometric parameters and specific organs (e.g., liver). Continuous functions could be derived for most system parameters describing a Caucasian population from 20 to 99 years of age with variability. Areas with sparse data were identified such as tissue composition, but knowledge gaps were filled with plausible qualified assumptions. The developed population was implemented in Matlab® and estimated system parameters from 1000 virtual individuals were in accordance with independent observed data showing the robustness of the developed population. CONCLUSIONS: The developed repository for aging subjects provides a singular specific source for key system parameters needed for physiologically based pharmacokinetic modeling and can in turn be used to investigate drug kinetics and drug-drug interaction magnitudes in the elderly.
引用
- Stader F, Siccardi M, Battegay M, et al. Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes. Clin Pharmacokinet. 2019. PMID: 30128967. doi:10.1007/s40262-018-0709-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。